AtriCure, Inc. (ATRC) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income $9.66M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income $526.00K; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income $208.00K; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$6.19M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | $9.66M | (m) | $153.60M | (m) | $3.77M* | $22.19M* | (m) | $26.40M | $82.56M | $471.00K |
| 2026-03-31 | Reported | (m) | $526.00K | (m) | $141.25M | (m) | $3.85M | -$4.00M | (m) | $24.23M | $84.55M | $286.00K |
| 2025-09-30 | Reported | (m) | $208.00K | (m) | $134.27M | (m) | $2.60M* | $26.72M* | (m) | $22.89M | $78.23M | $181.00K |
| 2025-06-30 | Reported | (m) | -$6.19M | (m) | $136.14M | (m) | $2.66M* | $21.62M* | (m) | $29.28M | $78.39M | $261.00K |
| 2025-03-31 | Reported | (m) | -$5.95M | (m) | $123.62M | (m) | $2.18M | -$11.03M | (m) | $22.53M | $76.05M | $239.00K |
| 2024-09-30 | Reported | (m) | -$7.41M | (m) | $115.91M | (m) | $3.61M* | $20.00M* | (m) | $20.96M | $73.24M | $322.00K |
| 2024-06-30 | Reported | (m) | -$7.17M | (m) | $116.27M | (m) | $2.38M* | $7.38M* | (m) | $20.42M | $73.60M | $253.00K |
| 2024-03-31 | Reported | (m) | -$10.92M | (m) | $108.85M | (m) | $2.77M | -$21.02M | (m) | $19.84M | $72.34M | $183.00K |
| 2023-09-30 | Reported | (m) | -$8.09M | (m) | $98.29M | (m) | $3.63M* | $1.52M* | (m) | $20.35M | $61.60M | $47.00K |
| 2023-06-30 | Reported | (m) | -$4.14M | (m) | $100.92M | (m) | $3.08M* | $3.01M* | (m) | $17.44M | $63.78M | $93.00K |
| 2023-03-31 | Reported | (m) | -$5.78M | (m) | $93.49M | (m) | $2.50M | -$4.08M | (m) | $15.33M | $60.06M | $78.00K |
| 2022-09-30 | Reported | (m) | -$10.72M | (m) | $83.25M | (m) | $5.14M* | -$1.78M* | (m) | $15.17M | $57.27M | $46.00K |
| 2022-06-30 | Reported | (m) | -$13.66M | (m) | $84.53M | (m) | $4.18M* | $4.23M* | (m) | $14.79M | $62.39M | $45.00K |
| 2022-03-31 | Reported | (m) | -$14.15M | (m) | $74.58M | (m) | $3.38M | -$24.63M | (m) | $13.63M | $56.12M | $56.00K |
| 2021-09-30 | Reported | (m) | $98.67M | (m) | $70.46M | (m) | $1.50M* | -$232.00K* | (m) | $11.28M | $49.87M | $38.00K |
| 2021-06-30 | Reported | (m) | -$15.08M | (m) | $71.38M | (m) | $4.21M* | -$4.53M* | (m) | $12.20M | $56.96M | $66.00K |
| 2021-03-31 | Reported | (m) | -$15.88M | (m) | $59.27M | (m) | $1.33M | -$9.32M | (m) | $11.22M | $49.21M | $31.00K |
| 2020-12-31 | Reported | (m) | -$17.50M | (m) | $57.73M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | Reported | (m) | -$3.99M | (m) | $54.76M | (m) | $1.26M* | $3.81M* | (m) | $10.58M | $33.56M | -$4.00K |
| 2020-06-30 | Reported | (m) | -$7.29M | (m) | $40.82M | (m) | $1.11M* | -$11.55M* | (m) | $10.04M | $24.90M | $12.00K |
| 2020-03-31 | Reported | (m) | -$15.45M | (m) | $53.23M | (m) | $1.83M | -$16.09M | (m) | $11.59M | $42.75M | $8.00K |
| 2019-12-31 | Reported | (m) | -$15.33M | (m) | $61.32M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | Reported | (m) | -$8.64M | (m) | $56.61M | (m) | $3.37M* | -$2.59M* | (m) | $10.15M | $40.28M | $75.00K |
| 2019-06-30 | Reported | (m) | -$3.84M | (m) | $58.91M | (m) | $2.75M* | $3.75M* | (m) | $9.80M | $37.93M | $10.00K |
| 2019-03-31 | Reported | (m) | -$5.32M | (m) | $53.97M | (m) | $1.71M | -$13.44M | (m) | $8.18M | $37.02M | $66.00K |
| 2018-12-31 | Reported | (m) | -$2.61M | (m) | $52.89M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | Reported | (m) | -$6.05M | (m) | $49.94M | (m) | $1.66M* | $5.21M* | (m) | $8.56M | $33.44M | $51.00K |
| 2018-06-30 | Reported | (m) | $958.00K | (m) | $51.80M | (m) | $1.39M* | -$935.00K* | (m) | $8.65M | $28.47M | $48.00K |
| 2018-03-31 | Reported | (m) | -$9.43M | (m) | $46.99M | (m) | $2.09M | -$9.43M | (m) | $9.06M | $34.88M | $48.00K |
| 2017-12-31 | Reported | (m) | -$2.13M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | Reported | (m) | -$6.85M | (m) | $42.15M | (m) | $1.65M* | $131.00K* | (m) | $7.97M | $29.80M | $26.00K |
| 2017-06-30 | Reported | (m) | -$6.36M | (m) | (m) | (m) | $1.76M* | -$1.06M* | (m) | $8.91M | $30.00M | $17.00K |
| 2017-03-31 | Reported | (m) | -$9.64M | (m) | (m) | (m) | $1.73M | -$9.55M | (m) | $9.55M | $30.10M | $23.00K |
| 2016-12-31 | Reported | (m) | -$7.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | Reported | (m) | -$6.29M | (m) | (m) | (m) | $1.76M* | (m) | (m) | $8.27M | $25.49M | $2.00K |
| 2016-06-30 | Reported | (m) | -$7.74M | (m) | (m) | (m) | $1.54M* | (m) | (m) | $9.12M | $27.43M | $17.00K |
| 2016-03-31 | Reported | (m) | -$9.42M | (m) | (m) | (m) | $2.80M | (m) | (m) | $8.56M | $26.77M | $5.00K |
| 2015-12-31 | Reported | (m) | -$10.63M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | Reported | (m) | -$6.13M | (m) | (m) | (m) | $4.21M* | (m) | (m) | $6.50M | $22.10M | $6.00K |
| 2015-06-30 | Reported | (m) | -$4.82M | (m) | (m) | (m) | $2.64M* | (m) | (m) | $5.86M | $22.07M | $8.00K |
| 2015-03-31 | Reported | (m) | -$5.14M | (m) | (m) | (m) | $1.43M | (m) | (m) | $5.61M | $21.27M | $6.00K |
| 2014-12-31 | Reported | (m) | -$4.78M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | Reported | (m) | -$803.00K | (m) | (m) | (m) | $1.91M* | (m) | (m) | $5.03M | $14.66M | $4.00K |
| 2014-06-30 | Reported | (m) | -$2.85M | (m) | (m) | (m) | $1.46M* | (m) | (m) | $4.57M | $17.07M | $5.00K |
| 2014-03-31 | Reported | (m) | -$7.92M | (m) | (m) | (m) | $1.02M | (m) | (m) | $4.00M | $21.58M | $27.00K |
| 2013-12-31 | Reported | (m) | -$4.84M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | Reported | (m) | -$2.61M | (m) | (m) | (m) | $739.00K* | $674.00K* | (m) | $3.24M | $14.06M | $4.00K |
| 2013-06-30 | Reported | (m) | -$1.64M | (m) | (m) | (m) | $736.00K* | -$258.00K* | (m) | $3.05M | $13.71M | $5.00K |
| 2013-03-31 | Reported | (m) | -$1.80M | (m) | (m) | (m) | $455.00K | -$2.57M | (m) | $3.51M | $12.38M | $5.00K |
| 2012-12-31 | Reported | (m) | -$1.85M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | Reported | (m) | -$2.53M | (m) | (m) | (m) | $977.00K* | -$463.00K* | (m) | $2.90M | $11.17M | $11.00K |
| 2012-06-30 | Reported | (m) | -$1.32M | (m) | (m) | (m) | $733.00K* | -$198.00K* | (m) | $2.88M | $11.15M | $6.00K |
| 2012-03-31 | Reported | (m) | -$1.50M | (m) | (m) | (m) | $662.00K | -$1.08M | (m) | $3.39M | $10.86M | $3.00K |
| 2011-12-31 | Reported | (m) | -$1.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | Reported | (m) | -$1.19M | (m) | (m) | (m) | $214.00K* | -$355.00K* | (m) | $3.07M | $9.21M | $12.00K |
| 2011-06-30 | Reported | (m) | -$771.00K | (m) | (m) | (m) | $249.27K* | $367.57K* | (m) | $2.88M | $10.17M | $9.00K |
| 2011-03-31 | Reported | (m) | -$1.07M | (m) | (m) | (m) | $388.73K | -$871.57K | (m) | $2.94M | $10.02M | $4.50K |
| 2010-09-30 | Reported | (m) | -$830.89K | (m) | (m) | (m) | $497.68K* | $317.07K* | (m) | $2.94M | $9.07M | $1.44K |
| 2010-06-30 | Reported | (m) | -$432.86K | (m) | (m) | (m) | (m) | (m) | (m) | $2.42M | $9.24M | $109.00 |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$9.45M | (m) | $534.53M | (m) | $9.05M | $57.33M | (m) | $99.21M | $311.02M | $1.28M |
| 2024-12-31 | Reported | (m) | -$40.01M | (m) | $465.31M | (m) | $11.46M | $12.20M | (m) | $96.18M | $291.36M | $1.02M |
| 2023-12-31 | Reported | (m) | -$26.68M | (m) | $399.25M | (m) | $12.00M | $4.48M | (m) | $73.92M | $253.14M | $591.00K |
| 2022-12-31 | Reported | (m) | -$42.67M | (m) | $330.38M | (m) | $16.88M | -$22.14M | (m) | $57.34M | $231.27M | $268.00K |
| 2021-12-31 | Reported | (m) | $55.20M | (m) | $274.33M | (m) | $9.75M | -$13.78M | (m) | $48.51M | $204.65M | $188.00K |
| 2021-09-30 | Rolling | (m) | $50.20M* | (m) | $258.84M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | Rolling | (m) | -$52.46M* | (m) | $243.13M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | Rolling | (m) | -$44.66M* | (m) | $212.58M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | Reported | (m) | -$44.23M | (m) | $206.53M | (m) | $5.26M | -$19.87M | $655.00K | $43.07M | $150.83M | $114.00K |
| 2020-12-31 | Rolling | (m) | -$44.23M* | (m) | $206.53M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | Rolling | (m) | -$42.06M* | (m) | $210.13M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | Rolling | (m) | -$46.70M* | (m) | $211.98M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | Rolling | (m) | -$43.26M* | (m) | $230.07M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | Reported | (m) | -$33.12M | (m) | $230.81M | (m) | $12.18M | -$15.81M | $635.00K | $41.23M | $167.14M | $199.00K |
| 2019-12-31 | Rolling | (m) | -$33.12M* | (m) | $230.81M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | Rolling | (m) | -$20.40M* | (m) | $222.38M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | Rolling | (m) | -$17.81M* | (m) | $215.71M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | Rolling | (m) | -$13.02M* | (m) | $208.60M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | Reported | (m) | -$17.13M | (m) | $201.63M | (m) | $6.21M | -$4.17M | $785.00K | $34.72M | $129.52M | $226.00K |
| 2018-12-31 | Rolling | (m) | -$17.13M* | (m) | $201.63M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | Rolling | (m) | -$16.66M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | Rolling | (m) | -$17.45M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | Rolling | (m) | -$24.77M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | Reported | (m) | -$24.98M | (m) | $174.72M | (m) | $6.38M | -$8.94M | $900.00K | $34.14M | $117.00M | $14.00K |
| 2017-12-31 | Rolling | (m) | -$24.98M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | Rolling | (m) | -$30.54M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | Rolling | (m) | -$29.98M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | Rolling | (m) | -$31.36M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | Reported | (m) | -$31.14M | (m) | $155.11M | (m) | $7.69M | -$15.12M | $625.00K | $35.82M | $106.42M | $40.00K |
| 2016-12-31 | Rolling | (m) | -$31.14M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | Rolling | (m) | -$34.07M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | Rolling | (m) | -$33.91M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | Rolling | (m) | -$31.00M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | Reported | (m) | -$26.72M | (m) | (m) | (m) | $13.45M | -$7.84M | (m) | $25.74M | $93.85M | $36.00K |
| 2015-12-31 | Rolling | (m) | -$26.72M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | Rolling | (m) | -$20.87M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | Rolling | (m) | -$15.54M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | Rolling | (m) | -$13.58M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | Reported | (m) | -$16.36M | (m) | (m) | (m) | $5.51M | (m) | (m) | $18.60M | $73.51M | $33.00K |
| 2014-12-31 | Rolling | (m) | -$16.36M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | Rolling | (m) | -$16.42M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | Rolling | (m) | -$18.23M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | Rolling | (m) | -$17.02M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | Reported | (m) | -$10.89M | (m) | (m) | (m) | $2.86M | -$5.22M | (m) | $13.44M | $57.01M | $18.00K |
| 2013-12-31 | Rolling | (m) | -$10.89M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | Rolling | (m) | -$7.91M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | Rolling | (m) | -$7.82M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | Rolling | (m) | -$7.50M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | Reported | (m) | -$7.20M | (m) | (m) | (m) | $2.98M | -$1.94M | (m) | $12.15M | $45.06M | $50.00K |
| 2012-12-31 | Rolling | (m) | -$7.20M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | Rolling | (m) | -$7.04M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | Rolling | (m) | -$5.70M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | Rolling | (m) | -$5.15M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | Reported | (m) | -$4.73M | (m) | (m) | (m) | $1.52M | -$1.99M | (m) | $11.86M | $39.87M | $31.00K |
| 2011-12-31 | Rolling | (m) | -$4.73M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | Reported | (m) | -$3.19M | (m) | (m) | (m) | $1.81M | -$33.00K | (m) | $11.53M | $37.05M | $19.00K |
| 2009-12-31 | Reported | (m) | -$15.51M | (m) | (m) | (m) | $1.36M | $419.95K | (m) | $11.41M | $35.11M | -$58.64K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |